A Prospective Study of Ranibizumab in the Treatment of Postoperative Recurrent Vitreous Haemorrhage of Diabetic Retinopathy

NCT05248334 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Diabetic Retinopathy
Postoperative Recurrent Vitreous Hemorrhage
Pars Plana Vitrectomy
Ranibizumab

Interventions

DRUG: Ranibizumab Injection
PROCEDURE: PPV

Sponsor

Tianjin Medical University Eye Hospital

Collaborators

[object Object]
[object Object]